Squarepoint
SONM icon

Squarepoint’s DNA X Inc SONM Stock Holding History

Squarepoint’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-203
Closed -$299K – 3660
2021
Q1 		$299K Sell
203
-5
-2% -$8.82K ﹤0.01% 2397
2020
Q4 		$271K Sell
208
-15
-7% -$16.4K ﹤0.01% 2283
2020
Q3 		$312K Buy
+223
New +$358K ﹤0.01% 1765
2019
Q3 		– Sell
-15
Closed -$353K – 2650
2019
Q2 		$353K Buy
+15
New +$381K ﹤0.01% 1851

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Squarepoint's SONM Position: Q2 2021 in Review

Squarepoint sold out of DNA X Inc (SONM) in Q2 2021, closing a stake of 203 shares — an estimated $299K sold.

Squarepoint first reported a position in SONM in Q2 2019 and held it in 4 quarters. The position peaked at $353K in Q2 2019. 17 funds tracked by Wall St. Rank hold SONM as of Q2 2021.

  • Squarepoint reported no remaining DNA X Inc position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 203 DNA X Inc shares in Q2 2021, an estimated $299K.
  • Squarepoint first reported a position in DNA X Inc in Q2 2019 and held it in 4 quarters.
  • Squarepoint's DNA X Inc position peaked at $353K in Q2 2019.
  • 17 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.